Reviva Pharmaceuticals Holdings, Inc. (RVPH): 25-NSE filed Jul 10, 2026

Form type
25-NSE
Filing date
Jul 10, 2026
Accession number
0001354457-26-000658
Filer
Reviva Pharmaceuticals Holdings, Inc. (CIK 1742927)